Alzamend Neuro, Inc. (ALZN)
1.68
+0.02
(+1.20%)
USD |
NASDAQ |
Sep 08, 16:00
Alzamend Neuro Market Cap : 7.150M for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 7.150M |
| September 04, 2026 | 7.065M |
| September 03, 2026 | 7.235M |
| September 02, 2026 | 7.235M |
| September 01, 2026 | 6.966M |
| August 31, 2026 | 6.810M |
| August 28, 2026 | 7.065M |
| August 27, 2026 | 7.086M |
| August 26, 2026 | 7.108M |
| August 25, 2026 | 6.810M |
| August 24, 2026 | 6.597M |
| August 21, 2026 | 6.639M |
| August 20, 2026 | 6.937M |
| August 19, 2026 | 6.469M |
| August 18, 2026 | 6.469M |
| August 17, 2026 | 6.724M |
| August 14, 2026 | 6.597M |
| August 13, 2026 | 6.214M |
| August 12, 2026 | 6.129M |
| August 11, 2026 | 6.256M |
| August 10, 2026 | 6.214M |
| August 07, 2026 | 5.831M |
| August 06, 2026 | 5.873M |
| August 05, 2026 | 6.086M |
| August 04, 2026 | 6.171M |
| Date | Value |
|---|---|
| August 03, 2026 | 5.703M |
| July 31, 2026 | 5.575M |
| July 30, 2026 | 5.746M |
| July 29, 2026 | 5.703M |
| July 28, 2026 | 5.575M |
| July 27, 2026 | 5.703M |
| July 24, 2026 | 5.660M |
| July 23, 2026 | 5.363M |
| July 22, 2026 | 5.746M |
| July 21, 2026 | 5.618M |
| July 20, 2026 | 5.363M |
| July 17, 2026 | 4.604M |
| July 16, 2026 | 4.642M |
| July 15, 2026 | 4.680M |
| July 14, 2026 | 4.604M |
| July 13, 2026 | 4.414M |
| July 10, 2026 | 4.490M |
| July 09, 2026 | 4.414M |
| July 08, 2026 | 4.375M |
| July 07, 2026 | 4.337M |
| July 06, 2026 | 4.414M |
| July 02, 2026 | 4.414M |
| July 01, 2026 | 4.261M |
| June 30, 2026 | 4.566M |
| June 29, 2026 | 4.414M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.782B |
| Alnylam Pharmaceuticals, Inc. | 34.66B |
| Anika Therapeutics, Inc. | 284.25M |
| Savara, Inc. | 1.121B |
| Vericel Corp. | 1.990B |
Market Cap Related Metrics
| Price to Book Value | 9.752 |
| Price | 1.68 |
| Earnings Yield | -172.4% |